Relationship between Pulmonary outcomes, biomarkers Of CF Disease, And Serum drug Levels in Subjects with The G551D-CFTR Mutation Treated With VX-770, An Investigational Oral Potentiator Of CFTR
暂无分享,去创建一个
J. Clancy | F. Accurso | M. Ashlock | B. Ramsey | M. Konstan | Q. Dong | M. Boyle | P. Campbell | J. Zha | C. Ordoñez